Cadila Healthcare fell 6.55% to Rs 381 at 13:34 IST on BSE after consolidated net profit fell 28.93% to Rs 337.60 crore on 0.51% increase in total income to Rs 2427.10 crore in Q2 September 2016 over Q2 September 2015.
The result was announced during trading hours today, 26 October 2016.Meanwhile, the BSE Sensex was down 202.03 points, or 0.72%, to 27,889.39.
On BSE, so far 2.52 lakh shares were traded in the counter, compared with average daily volume of 83,845 shares in the past one quarter. The stock hit a high of Rs 410 and a low of Rs 374.10 so far during the day. The stock hit a record high of Rs 437 on 5 November 2015. The stock hit a 52-week low of Rs 295.50 on 18 January 2016. The stock had outperformed the market over the past 30 days till 25 October 2016, rising 3.70% compared with 0.72% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.98% as against Sensex's 0.24% rise.
The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.
Cadila Healthcare is a global pharmaceutical company that discovers, manufactures and markets a broad range of healthcare therapies.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
